Vaccines Against Bacterial and Viral Infections (2023)

Vaccines Against Bacterial and Viral Infections (Course #: 0158.1270)


Daniel Cohen (Tel Aviv University, Israel)

Khitam Muhsen (Tel Aviv University, Israel)

Elizabeth Miller (London School of Hygiene & Tropical Medicine, UK; Tel Aviv University, Israel)

Jonathan Zenilman (Johns Hopkins University, USA)

Myron Levine (University of Maryland, Baltimore, USA)

Ronald Ellis (Editor-in-Chief, Human Vaccines & Immunotherapeutics)

Michal Mandelboim (Tel Aviv University, Israel)

Orna Mor (Tel Aviv University, Israel)

Date and Time:

July 9-13, 2023

M, W, Th 14:00-18:30 | S, T 14:00-19:00


Room TBA, Sackler Faculty of Medicine

Final Exam:

July 14, 2023 | 9:00-11:00 | Room TBA





Registration Status:



Apply now: English (International) | Hebrew (Israeli)

Course Syllabus

The course syllabus can be found here.

Course Description

This course will cover key concepts in vaccinology in general, integrating references to vaccine development, evaluation and current immunization strategies against COVID-19 and other emerging diseases such as Ebola-Sudan and monkeypox.

The course will review the evolution of vaccine development approaches and present the characteristics of currently licensed vaccines and those authorized for emergency use. The process from conception to R&D, and to first-in-man studies and further evaluation of safety, immunogenicity and efficacy of candidate vaccines through clinical development phases will be presented and analyzed.

Methods to quantify the induced immune response and the protective efficacy conferred by vaccine candidates will be reviewed, and the notion of correlates of protection will be elaborated upon. Post-licensure approaches in the evaluation of vaccines for effectiveness, impact and signal of detection of adverse events will be presented and discussed.

Highlights and challenges of the present immunization programs worldwide will be described vis-à-vis the burden of corresponding vaccine-preventable diseases. Special attention will be given to the analysis of psychosocial factors associated with hesitancy to vaccination in various populations. Lecturers will present accomplishments and challenges with selected licensed and investigational vaccines.

Throughout, the course will emphasize the importance of the use of advanced epidemiological tools to prioritize the development of new vaccines and assess existing immunization programs.


Participants must pass the final exam with a grade of at least 60 (D) to receive academic credit for the course. Non-credit participants are not required to take the final exam.

Lecturer Bio

Prof. Daniel Cohen, PhD, MPH

Professor, School of Public Health, Tel Aviv University, Israel

Prof. Khitam Muhsen, PhD

Associate Professor, School of Public Health, Tel Aviv University, Israel

Prof. Elizabeth Miller, PhD

Professor, London School of Hygiene and Tropical Medicine, United Kingdom; School of Public Health, Tel Aviv University, Israel

Prof. Jonathan Zenliman, MD

Professor, Bloomberg School of Public Health, Johns Hopkins University

Prof. Myron M. Levine, MD, DTPH

Professor, School of Medicine, University of Maryland, Baltimore, USA


Dr. Ronald Ellis, PhD

Editor-in-Chief, "Human Vaccines and Immunotheraputics"

Prof. Michal Mandelboim, PhD

Associate Professor, School of Public Health, Tel Aviv University, Israel

Prof. Orna Mor, PhD

Associate Professor, School of Public Health, Tel Aviv University, Israel


Contact Information

International: Ms. Saritte Perlman |  | +972-(0)3-640-7796‚Äč

Israeli:  Hebrew Website

Tel Aviv University makes every effort to respect copyright. If you own copyright to the content contained
here and / or the use of such content is in your opinion infringing, Contact us as soon as possible >>